Skip to main content
. 2019 Aug 30;9(8):e029686. doi: 10.1136/bmjopen-2019-029686

Table 3.

Frequency of symptom combinations for headache and cognitive features in 1 or 6 months before diagnosis

Brain tumour status PPV††(%) PLR (95% CI)
Case (n=8184) Control (n=28 110)
Number with symptoms Sensitivity Number with symptoms Specificity
Headache
 Headache plus (1 month) 476 (5.8) 81 (99.7) 0.7 18.1 (16.6 to 19.8)
 Headache only (1 month) 687 (8.4) 437 (98.4) 0.1 3.92 (3.65 to 4.21)
 Headache plus (6 months) 569 (7.0) 116 (99.6) 0.6 16.3 (15.0 to 17.6)
 Headache only (6 months) 594 (7.3) 402 (98.6) 0.1 3.57 (3.30 to 3.86)
 Headache +depression (6 months) 83 (1.0) 32 (99.9) 0.4 9.90 (7.99 to 12.3)
 Headache +cognition (6 months) 47 (0.6) 2 (100.0) 5.9 165 (123 to 221)
 Headache +weakness (6 months) 35 (0.4) 1 (100.0) 4.4 122 (87 to 171)
 Headache +nausea (6 months) 167 (2.0) 11 (100.0) 2.0 55 (47 to 64)
Cognitive*
 Cognitive plus (1 month) 325 (4.0) 48 (99.8) 1.5 39 (35 to 44)
 Cognitive only (1 month) 435 (5.3) 140 (99.5) 0.7 18.9 (17.2 to 20.7)
 Cognitive plus (6 months) 379 (4.6) 69 (99.8) 1.2 32.0 (29.0 to 35.3)
 Cognitive only (6 months) 381 (4.7) 119 (99.6) 0.7 19.6 (17.8 to 21.7)
 Cognitive +depression (6 months) 62 (0.8) 20 (99.9) 0.5 12.9 (10.1 to 16.6)
 Cognitive +headache (6 months) 111 (1.4) 4 (100.0) 7.2 205 (169 to 249)
 Cognitive +weakness (6 months) 19 (0.2) 1 (100.0) 9.6 282 (176 to 451)
 Cognitive +nausea (6 months) 60 (0.7) 5 (100.0) 3.5 96 (74 to 124)

*This cognitive variable is a composite of cognition, concentration and confusion symptoms.

† Calculated after weighting for population sampling.

PLR, positive likelihood ratio; PPV, positive predictive value.